Point72 Asset Management
SBBP

Point72 Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Point72 Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-653,000
Closed -$1.36M – 1195
2019
Q4 		$1.36M Buy
653,000
+178,000
+37% +$341K 0.01% 673
2019
Q3 		$1.14M Buy
+475,000
New +$1.28M 0.01% 671

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asset Management's SBBP Position: Q1 2020 in Review

Point72 Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 653,000 shares — an estimated $1.36M sold.

Point72 Asset Management first reported a position in SBBP in Q3 2019 and held it in 2 quarters. The position peaked at $1.36M in Q4 2019. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

  • Point72 Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
  • Point72 Asset Management sold 653,000 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $1.36M.
  • Point72 Asset Management first reported a position in Strongbridge Biopharma plc. in Q3 2019 and held it in 2 quarters.
  • Point72 Asset Management's Strongbridge Biopharma plc. position peaked at $1.36M in Q4 2019.
  • 60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.